NOVAREX Co.,Ltd. (KOSDAQ:194700)

Market Cap	256.31B +50.0%
Revenue (ttm)	404.26B +35.8%
Net Income	35.42B +53.9%
EPS	2,000.00 +53.8%
Shares Out	17.20M
PE Ratio	7.45
Forward PE	n/a
Dividend	400.00 (2.63%)
Ex-Dividend Date	Dec 29, 2025

Volume	68,491
Average Volume	45,776
Open	14,620
Previous Close	14,600
Day's Range	14,420 - 15,230
52-Week Range	9,730 - 22,100
Beta	0.22
RSI	60.97
Earnings Date	Apr 3, 2026

About NOVAREX

NOVAREX Co.,Ltd. manufactures, wholesales, and retails health and functional foods in South Korea and internationally. It offers lactic acid bacteria, omega-3, icle time, eye health, diet, boswellia, and lutein and zeaxanthin, as well as vitamin and mineral products in the form of tablets, soft and hard capsules, powder, liquid, gel, and jellies. The company was formerly known as Health Science Co., Ltd. and changed its name to NOVAREX Co.,Ltd. in November 2013. NOVAREX Co.,Ltd. was founded in 1995 and is headquartered in Cheongju-si, South Kor...

• Industry: Pharmaceutical Preparations
• Founded: 1995
• Employees: 464
• Stock Exchange: KOSDAQ
• Ticker Symbol: 194700

Financial Performance

In 2025, NOVAREX's revenue was 404.26 billion, an increase of 35.78% compared to the previous year's 297.73 billion. Earnings were 35.42 billion, an increase of 53.87%.